December 9, 2021
FDA: Edge Pharma issues nationwide recall of all drug products
Editor's Note
The Food and Drug Administration (FDA) on December 7 announced that Edge Pharma, LLC (Colchester, Vermont) has issued a nationwide recall of all drug products.
The recall was initiated because of process issues that could lead to a lack of sterility assurance for products intended to be sterile and could affect the safety and quality of nonsterile products.
To date, Edge Pharma has not received and is not aware of any adverse events related to this recall.
Free Daily News
- United Surgical Partners agrees to $1.48M settlement in 401(k) fee lawsuit
- Healthcare M&A activity set to rebound in 2025 amid stricter state oversight
- High participation in ASCQR program continues, March deadline for reconsideration requests
- Study: Preoperative stereotactic radiosurgery shows promise in brain metastases management
- Senate report: Private equity endangers patient care in underserved hospitals
- Study: Postoperative thirst often overlooked by OR, ward nurses
- FDA draft guidance addresses pulse oximeter accuracy, AI devices
- AAMI updates sterilization materials compatibility guidance
- Study: Esophagectomy outcomes worse at private equity hospitals
- Study: Black CABG patients disadvantaged in accessing best hospitals
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement